middle.news
PainChek’s US opportunity meets a harder cash test
9:46am on Wednesday 23rd of September, 2026 AEST
•
Healthcare technology
Read Story
PainChek’s US opportunity meets a harder cash test
9:46am on Wednesday 23rd of September, 2026 AEST
Key Points
11.4% increase in customer revenue to $3.74 million
Implemented ARR rose 24.6% to $4.46 million
$8.94 million net loss and $9.24 million operating cash outflow
$5.5 million convertible note carries 12% annual cash interest
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
Painchek (ASX:PCK)
OPEN ARTICLE